Swiss pharma giant Novartis mulls sale of its Indian operations
KEYSTONE
Novartis has announced that it is considering various strategic options regarding the future of its Indian subsidiary Novartis India Limited, which is listed on the Bombay stock exchange. These include the possibility of selling its stake in the company.
This content was published on
2 minutes
“This strategic review will include a valuation of the 70.68% stake in the company,” Novartis India Limited said in a statement. This does not include the subsidiary Novartis Healthcare Private Limited, a separate entity wholly owned by the Basel-based group.
The latter includes the Novartis Corporate Center in Hyderabad, the commercial arm of Novartis in India, as well as research and development teams currently conducting clinical trials at more than 300 sites in the country. Novartis says it remains committed to its operations in India, where it employs more than 8100 associates.
There is no guarantee that this strategic review will be concluded in 2024 or that it will result in a transaction, it says.
At the end of December, Novartis India Limited recorded sales of 2.54 billion rupees (CHF26.9 million) in the first nine months of its offbeat financial year. According to Fierce Pharma, a specialised industry website, the Novartis India Limited subsidiary is involved in the distribution of medicines that are no longer protected by patent, particularly in the treatment of bone, pain, immunology and neuroscience.
In 2022, the distribution rights for some of this entity’s medicines were transferred to the Indian company Dr Reddy’s Laboratories, which, according to various Indian media, is among the potential buyers.
Translated from French by DeepL/ac
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Rhine flooding: Swiss to invest CHF1 billion with Austria
This content was published on
As part of an international agreement with Austria, the Swiss government wants to pump CHF1 billion ($1.1 billion) into flood protection measures along the Rhine over the next three decades.
Swiss government proposes CHF10 million UNRWA donation
This content was published on
After months of debate, Switzerland plans to give CHF10 million ($11 million) to the UN agency this year, rather than the CHF20 million initially foreseen.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.